Glucose Health Debt/Equity Ratio 2014-2019 | GLUC

Glucose Health debt/equity ratio from 2014 to 2019. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Glucose Health Debt/Equity Ratio 2014-2019 | GLUC

Glucose Health debt/equity ratio from 2014 to 2019. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$206.3B
Stryker (SYK)$148B
Boston Scientific (BSX)$133.7B
EssilorLuxottica (ESLOY)$111.2B
Medtronic (MDT)$110.6B
Haleon (HLN)$44B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.9B
ResMed (RMD)$36.6B
Terumo (TRUMY)$30.3B
Koninklijke Philips (PHG)$25.5B
Zimmer Biomet Holdings (ZBH)$22.3B
Insulet (PODD)$18.7B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.2B
BellRing Brands (BRBR)$9.9B
Bio-Rad Laboratories (BIO)$9.5B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.4B
Haemonetics (HAE)$4.4B
Prestige Consumer Healthcare (PBH)$4.2B
Perrigo (PRGO)$3.9B
ICU Medical (ICUI)$3.9B
Envista Holdings (NVST)$3.8B
Agios Pharmaceuticals (AGIO)$3.3B
Neogen (NEOG)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.8B